Wells Fargo’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $761K | Sell |
|
|||||
|
2024
Q4 | $3.17M | Sell |
|
|||||
|
2024
Q3 | $2.83M | Sell |
|
|||||
|
2024
Q2 | $2.8M | Sell |
|
|||||
|
2024
Q1 | $4.83M | Buy |
|
|||||
|
2023
Q4 | $4.24M | Buy |
|
|||||
|
2023
Q3 | $2.79M | Sell |
|
|||||
|
2023
Q2 | $4.34M | Buy |
|
|||||
|
2023
Q1 | $2.58M | Buy |
|
|||||
|
2022
Q4 | $1.59M | Sell |
|
|||||
|
2022
Q3 | $1.51M | Sell |
|
|||||
|
2022
Q2 | $1.89M | Sell |
|
|||||
|
2022
Q1 | $2.66M | Sell |
|
|||||
|
2021
Q4 | $4.05M | Buy |
|
|||||
|
2021
Q3 | $2.21M | Buy |
|
|||||
|
2021
Q2 | $2.24M | Sell |
|
|||||
|
2021
Q1 | $2.09M | Sell |
|
|||||
|
2020
Q4 | $3.54M | Buy |
|
|||||
|
2020
Q3 | $2.17M | Buy |
|
|||||
|
2020
Q2 | $1.37M | Buy |
|
|||||
|
2020
Q1 | $464K | Buy |
|
|||||
|
2019
Q4 | $841K | Buy |
|
|||||
|
2019
Q3 | $175K | Buy |
|
|||||
|
2019
Q2 | $269K | Sell |
|
|||||
|
2019
Q1 | $307K | Sell |
|
|||||
|
2018
Q4 | $488K | Buy |
|
|||||
|
2018
Q3 | $558K | Buy |
|
|||||
|
2018
Q2 | $426K | Sell |
|
|||||
|
2018
Q1 | $534K | Buy |
|
|||||
|
2017
Q4 | $323K | Sell |
|
|||||
|
2017
Q3 | $548K | Buy |
|
|||||
|
2017
Q2 | $409K | Sell |
|
|||||
|
2017
Q1 | $1.43M | Sell |
|
|||||
|
2016
Q4 | $1.43M | Buy |
|
|||||
|
2016
Q3 | $224K | Buy |
|
|||||
|
2016
Q2 | $452K | Buy |
|
|||||
|
2016
Q1 | $290K | Sell |
|
|||||
|
2015
Q4 | $587K | Buy |
|
|||||
|
2015
Q3 | $202K | Sell |
|
|||||
|
2015
Q2 | $192K | Buy |
|
|||||
|
2015
Q1 | $103K | Buy |
|
|||||
|
2014
Q4 | $14K | Buy |
|
|||||
|
2014
Q3 | $11K | Sell |
|
|||||
|
2014
Q2 | $21K | Buy |
|